These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31665736)

  • 21. Clinical utility of computed tomographic lung volumes in patients with chronic obstructive pulmonary disease.
    Lee JS; Lee SM; Seo JB; Lee SW; Huh JW; Oh YM; Lee SD
    Respiration; 2014; 87(3):196-203. PubMed ID: 24334816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
    Ong KC; Lu SJ; Soh CS
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):91-6. PubMed ID: 18046907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts.
    Abu Hussein N; Ter Riet G; Schoenenberger L; Bridevaux PO; Chhajed PN; Fitting JW; Geiser T; Jochmann A; Joos Zellweger L; Kohler M; Maier S; Miedinger D; Schafroth Török S; Scherr A; Siebeling L; Thurnheer R; Tamm M; Puhan MA; Leuppi JD
    Respiration; 2014; 88(3):208-14. PubMed ID: 25115178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BODE-index, modified BODE-index and ADO-score in chronic obstructive pulmonary disease: relationship with COPD phenotypes and CT lung density changes.
    Camiciottoli G; Bigazzi F; Bartolucci M; Cestelli L; Paoletti M; Diciotti S; Cavigli E; Magni C; Buonasera L; Mascalchi M; Pistolesi M
    COPD; 2012 Jun; 9(3):297-304. PubMed ID: 22432964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.
    Bloom CI; Ricciardi F; Smeeth L; Stone P; Quint JK
    BMC Med; 2019 Apr; 17(1):73. PubMed ID: 30947728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China.
    Hu YH; Liang ZY; Xu LM; Xu WH; Liao H; Li R; Wang K; Xu Y; Ou CQ; Chen X
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3011-3019. PubMed ID: 30319249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified BODE Index to Predict Mortality in Individuals With COPD: The Role of 4-Min Step Test.
    Vieira EB; Degani-Costa LH; Amorim BC; Oliveira LB; Miranda-Silva T; Sperandio PC; Medeiros WM; Arbex FF; Ramos RP; Nery LE
    Respir Care; 2020 Jul; 65(7):977-983. PubMed ID: 31992673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in mortality in patients with COPD.
    de Torres JP; Cote CG; López MV; Casanova C; Díaz O; Marin JM; Pinto-Plata V; de Oca MM; Nekach H; Dordelly LJ; Aguirre-Jaime A; Celli BR
    Eur Respir J; 2009 Mar; 33(3):528-35. PubMed ID: 19047315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD.
    Liu SF; Wang CC; Chin CH; Chen YC; Lin MC
    Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation.
    Moberg M; Vestbo J; Martinez G; Williams JE; Ladelund S; Lange P; Ringbaek T
    COPD; 2014 Aug; 11(4):381-7. PubMed ID: 24111845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BODE index after lung volume reduction surgery correlates with survival.
    Imfeld S; Bloch KE; Weder W; Russi EW
    Chest; 2006 Apr; 129(4):873-8. PubMed ID: 16608932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of BODE and ADO Indices in Predicting COPD-Related Medical Costs.
    Li CL; Chang HC; Tseng CW; Tsai YC; Liu JF; Tsai ML; Lin MC; Liu SF
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984578
    [No Abstract]   [Full Text] [Related]  

  • 36. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease.
    Ferrari R; Tanni SE; Caram LM; Naves CR; Godoy I
    Health Qual Life Outcomes; 2011 Dec; 9():112. PubMed ID: 22152155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BODE-Index vs HADO-score in chronic obstructive pulmonary disease: Which one to use in general practice?
    Esteban C; Quintana JM; Moraza J; Aburto M; Aguirre U; Aguirregomoscorta JI; Aizpiri S; Basualdo LV; Capelastegui A
    BMC Med; 2010 May; 8():28. PubMed ID: 20497527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
    Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.